Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
SCG101 / SCG Cell Therapy
TCR-T, NCT05417932: A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma	Recruiting	1/2	46	US, RoW	SCG101	SCG Cell Therapy Pte. Ltd.	Hepatitis B Virus Related Hepatocellular Carcinoma, Hepatocellular Carcinoma Recurrent	09/25	10/25
CTR20222173: Phase I clinical study of SCG101 in the treatment of hepatitis B virus-related hepatocellular carcinoma	Recruiting	1	32	China	SCG101 - SCG Cell Therapy	Xinghande Biopharmaceutical (Dalian) Co., Ltd.	Hepatitis B virus related hepatocellular carcinoma
NCT05339321: Autologous HBV-specific T Cell Receptor Engineered T Cells (TCR-T) in Patients With HBV-related Advanced HCC	Recruiting	1	36	RoW	SCG101, PD1/PD-L1 checkpoint inhibitor	Peking Union Medical College Hospital	Hepatocellular Carcinoma	07/23	12/23